Squarepoint’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
116,379
+11,723
+11% +$23.5K ﹤0.01% 3754
2025
Q4
$143K Sell
104,656
-163,388
-61% -$216K ﹤0.01% 3959
2025
Q3
$332K Buy
268,044
+249,978
+1,384% +$298K ﹤0.01% 3585
2025
Q2
$20.4K Sell
18,066
-308,459
-94% -$410K ﹤0.01% 4390
2025
Q1
$477K Buy
326,525
+306,180
+1,505% +$577K ﹤0.01% 3345
2024
Q4
$43.3K Sell
20,345
-168,152
-89% -$415K ﹤0.01% 4867
2024
Q3
$528K Buy
188,497
+61,869
+49% +$165K ﹤0.01% 3049
2024
Q2
$295K Buy
+126,628
New +$374K ﹤0.01% 3440
2023
Q4
Sell
-121,792
Closed -$386K 3970
2023
Q3
$386K Buy
121,792
+71,855
+144% +$315K ﹤0.01% 2978
2023
Q2
$248K Sell
49,937
-6,838
-12% -$37K ﹤0.01% 3087
2023
Q1
$280K Sell
56,775
-143,589
-72% -$921K ﹤0.01% 2614
2022
Q4
$1.26M Sell
200,364
-45,958
-19% -$425K 0.01% 1661
2022
Q3
$2.66M Buy
+246,322
New +$3.35M 0.01% 1131
2022
Q2
Sell
-269,320
Closed -$2.45M 2846
2022
Q1
$2.45M Buy
+269,320
New +$2.81M 0.01% 1036
2021
Q1
Sell
-15,792
Closed -$399K 3056
2020
Q4
$399K Buy
15,792
+9,892
+168% +$322K ﹤0.01% 1983
2020
Q3
$222K Buy
+5,900
New +$222K ﹤0.01% 2014
2020
Q1
Sell
-54,596
Closed -$1.42M 1825
2019
Q4
$1.42M Buy
54,596
+46,049
+539% +$1.27M 0.01% 1109
2019
Q3
$233K Sell
8,547
-1,854
-18% -$52.8K ﹤0.01% 2012
2019
Q2
$279K Sell
10,401
-2,599
-20% -$72.4K ﹤0.01% 1955
2019
Q1
$376K Buy
+13,000
New +$377K ﹤0.01% 1636

Other funds holding ALLO